Bell’s palsy following growth hormone therapy in a patient with Prader-Willi syndrome: The first report

Dalili, Setila, Bidabadi, Elham, Behnam, Babak
Published: February 20, 2018
Genet. Mol. Res. 17(1): gmr16039877
DOI: https://doi.org/10.4238/gmr16039877

Cite this Article:
S. Dalili, E. Bidabadi, B. Behnam (2018). Bell’s palsy following growth hormone therapy in a patient with Prader-Willi syndrome: The first report. Genet. Mol. Res. 17(1): gmr16039877. https://doi.org/10.4238/gmr16039877

About the Authors
Dalili, Setila, Bidabadi, Elham, Behnam, Babak

Corresponding Author
Babak Behnam
Email: Babak.Behnam@nih.gov; b_behnam@yahoo.com

ABSTRACT

Prader–Willi syndrome (PWS) is a complex genetic disorder with different manifestations in infancy and childhood including obesity, type 2 diabetes mellitus, mild to moderate intellectual impairment and learning disabilities. In this syndrome, growth hormone therapy improves outcomes. For the first time, here we report a 11-year-old boy with PWS who presented with three episodes of unilateral facial palsy after starting growth hormone therapy.

Key words: Prader-Willi syndrome, Bell’s palsy, Growth Hormone, Growth hormone.

Back To Top